• #LGM Pharma is a Terlipressin CAS# 14636-12-5 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 14636-12-5
  • AHFC code:
  • Synonyms: N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin Terlipressina [INN-Spanish] Terlipressine [INN-French] Terlipressinum [INN-Latin]
  • ATC Code: H01BA04
  • Chemical Formula: C19H27NO3
  • Molecular Weight: 1227.372
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB02638 (EXPT03310)
  • SMILES: NCCCC[C,H](NC(=O)[C,,H]1CCCN1C(=O)[C,,H]1CSSC[C,H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C,,H](CC2=CC=C(O)C=C2)C(=O)N[C,,H](CC2=CC=CC=C2)C(=O)N[C,,H](CCC(N)=O)C(=O)N[C,,H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
  • InChl: BENFXAYNYRLAIU-QSVFAHTRSA-N
  • PubChem: 72081
  • IUPAC:

Additional Details

Indication:
Commonly used to stop bleeding of varices in the food pipe (oesophagus).
Pharmacodynamics:
Terlipressin is a medicine similar to a naturally occurring hormone present in the body, known as antidiuretic hormone (ADH) or vasopressin. ADH has two main effects in the body. Firstly, it causes narrowing of blood vessels (vasoconstriction), thereby limiting blood flow to a particular area of the body. It also acts on receptors in the kidney to retain water in the body, which helps to prevent excessive loss of water in the urine.
Mode of Action:
Terlipressin, an analogue of vasopressin, acts on three different receptors, vasopressin receptor V1a (which initiates vasoconstriction, liver gluconeogenesis, platelet aggregation and release of factor VIII), vasopressin receptor V1b (which mediates corticotrophin secretion from the pituitary) and vasopressin receptor V2 which controls free water reabsorption in the renal medullar. The binding of terlipressin to the V2 receptor activates adenylate cyclase which causes the release of aquaporin 2 channels into the cells lining the renal medullar duct. This allows water to be reabsorbed down an osmotic gradient so the urine is more concentrated.
Metabolism:
Toxicity:
General Reference:
Pesaturo AB, Jennings HR, Voils SA: Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother. 2006 Dec;40(12):2170-7. Epub 2006 Dec 5. Pubmed Klein M, Weksler N, Borer A, Koyfman L, Kesslin J, Gurman GM: Terlipressin facilitates transport of septic patients treated with norepinephrine. Isr Med Assoc J. 2006 Oct;8(10):691-3. Pubmed Leone M, Charvet A, Delmas A, Albanese J, Martin C, Boyle WA: Terlipressin: a new therapeutic for calcium-channel blockers overdose. J Crit Care. 2005 Mar;20(1):114-5. Pubmed Matok I, Vard A, Efrati O, Rubinshtein M, Vishne T, Leibovitch L, Adam M, Barzilay Z, Paret G: Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock. 2005 Apr;23(4):305-10. Pubmed Kam PC, Williams S, Yoong FF: Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia. 2004 Oct;59(10):993-1001. Pubmed
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials

 

Related YouTube Videos